Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
Public ClinicalTrials.gov record NCT00763321. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Open-Label Period Followed by a Randomized, Double-blind Placebo-controlled Study of the Analgesic Efficacy of Extended-release Hydrocodone/Acetaminophen (Vicodin CR) Compared to Placebo in Subjects With Chronic Low Back Pain
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of the study is to test the efficacy of 2 tablets (twice daily) of ABT-712, compared to placebo, administered over a 4-week period in participants with moderate to severe mechanical chronic low back pain (CLBP).
Study identification
- NCT ID
- NCT00763321
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 287 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2008
- Primary completion
- Mar 31, 2009
- Completion
- Mar 31, 2009
- Last update posted
- Feb 5, 2014
2008 – 2009
United States locations
- U.S. sites
- 31
- U.S. states
- 20
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 10044 | Huntsville | Alabama | 35801 | — |
| Site Reference ID/Investigator# 10070 | Burbank | California | 91505 | — |
| Site Reference ID/Investigator# 10050 | San Diego | California | 92108 | — |
| Site Reference ID/Investigator# 10060 | Atlantis | Florida | 33462 | — |
| Site Reference ID/Investigator# 10069 | Hollywood | Florida | 33023 | — |
| Site Reference ID/Investigator# 10045 | Kissimmee | Florida | 347411 | — |
| Site Reference ID/Investigator# 10061 | Tampa | Florida | 33603 | — |
| Site Reference ID/Investigator# 10054 | Atlanta | Georgia | 30327 | — |
| Site Reference ID/Investigator# 10071 | Marietta | Georgia | 30060 | — |
| Site Reference ID/Investigator# 13604 | Chicago | Illinois | 60654 | — |
| Site Reference ID/Investigator# 10053 | Evansville | Indiana | 47714 | — |
| Site Reference ID/Investigator# 10055 | Newburgh | Indiana | 47630 | — |
| Site Reference ID/Investigator# 10043 | Valparaiso | Indiana | 46383 | — |
| Site Reference ID/Investigator# 10072 | Prairie Village | Kansas | 66206 | — |
| Site Reference ID/Investigator# 10041 | Pasadena | Maryland | 21122 | — |
| Site Reference ID/Investigator# 10049 | Springfield | Massachusetts | 01103 | — |
| Site Reference ID/Investigator# 10062 | Biloxi | Mississippi | 39531 | — |
| Site Reference ID/Investigator# 10066 | Florissant | Missouri | 63031 | — |
| Site Reference ID/Investigator# 10073 | St Louis | Missouri | 63141 | — |
| Site Reference ID/Investigator# 10056 | Omaha | Nebraska | 68134 | — |
| Site Reference ID/Investigator# 10075 | Williamsville | New York | 14221 | — |
| Site Reference ID/Investigator# 10065 | Winston-Salem | North Carolina | 27103 | — |
| Site Reference ID/Investigator# 10067 | Fargo | North Dakota | 58104 | — |
| Site Reference ID/Investigator# 10047 | Oklahoma City | Oklahoma | 73103 | — |
| Site Reference ID/Investigator# 10052 | Altoona | Pennsylvania | 16602 | — |
| Site Reference ID/Investigator# 10042 | Bridgeville | Pennsylvania | 15017 | — |
| Site Reference ID/Investigator# 10063 | Greer | South Carolina | 29650 | — |
| Site Reference ID/Investigator# 10046 | Austin | Texas | 78705 | — |
| Site Reference ID/Investigator# 10058 | Austin | Texas | 78756 | — |
| Site Reference ID/Investigator# 10059 | Dallas | Texas | 75230 | — |
| Site Reference ID/Investigator# 10048 | Chesapeake | Virginia | 23320 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00763321, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 5, 2014 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00763321 live on ClinicalTrials.gov.